Making steady progress on direct cardiac reprogramming toward clinical application

Kenji Miki; Yoshinori Yoshida; Shinya Yamanaka

doi:10.1161/CIRCRESAHA.113.301788

Making steady progress on direct cardiac reprogramming toward clinical application

Circ Res. 2013 Jun 21;113(1):13-5. doi: 10.1161/CIRCRESAHA.113.301788.

Authors

Kenji Miki¹, Yoshinori Yoshida, Shinya Yamanaka

Affiliation

¹ Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.

PMID: 23788502
DOI: 10.1161/CIRCRESAHA.113.301788

Abstract

A new report demonstrates direct cardiac reprogramming in human cells for the first time and points to the possibility of moving this technology toward clinical applications.

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Cell Transdifferentiation / physiology*
Fibroblasts / cytology*
Gene Expression Regulation / physiology*
Humans
Myocytes, Cardiac / cytology*
Phenotype*